Testing version — LOERadar is in active testing. Features and data may change.
JUVMO (COPACKAGED) (TAVAPADON) | LOERadar
Not in the current Orange Book — This application is not listed in FDA's current Orange Book data files (no listed patents or exclusivities). Product and approval data shown are from FDA's Drugs@FDA database.
JUVMO (COPACKAGED)
NDANot in Orange Book
TAVAPADON | N220415 | ABBVIE
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (5)
Sort:
#002 — 5MG
▾
TABLET;ORAL | Approved: Sep. 25, 2026
#003 — 10MG
▾
TABLET;ORAL | Approved: Sep. 25, 2026
#004 — 15MG
▾
TABLET;ORAL | Approved: Sep. 25, 2026
#005 — 15MG
▾
TABLET; ORAL | Approved: Sep. 25, 2026
#001 — 0.25MG;1MG
▴
TABLET;ORAL | Approved: Sep. 25, 2026
No patent or exclusivity listings for this strength.